Division of Cell Biology, Department of Experimental and Clinical Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
J Pain. 2012 May;13(5):459-66. doi: 10.1016/j.jpain.2012.01.446. Epub 2012 Apr 3.
We examined the relationship between estrogen and pain in women undergoing in vitro fertilization (IVF). Quantitative sensory tests (QST) were performed twice during the IVF-regimen: once during hormonal down-regulation and once during hormonal up-regulation. A group of healthy men and a group of women using monophasic contraceptives were also examined, to control for session-to-session effects. Among the women undergoing IVF, serum 17β-estradiol levels differed strongly between treatments as expected, and increased from 65.7 (SD = 26) pmol/L during the down-regulation phase, to 5,188 (SD = 2,524) pmol/L during the up-regulation phase. Significant outcomes in the QST were only seen for temperature perception thresholds (1.7 °C versus 2.2 °C; P = .003) and cold pain threshold (11.5 °C versus 14.5 °C; P = .04). A similar change in cold pain threshold was also seen in the 2 control groups, however, and statistical analysis suggested that this change was due to a session-to-session effect rather than being the result of hormonal modulation. Heat pain thresholds, heat tolerance, pressure pain thresholds, and the cold pressor test showed no significant differences between sessions. These data demonstrate that pain perception and pain thresholds in healthy women show little, if any, changes even with major variations in serum estradiol levels.
This study shows that pain perception and tolerance in women undergoing in vitro fertilization do not vary, despite the dramatic changes in 17β-estradiol levels induced by the treatment regimen. The result thus suggests that in humans, contrary to experimental animals, changes in estrogen levels have little influence on pain sensitivity.
本研究旨在探讨接受体外受精(IVF)的女性中雌激素与疼痛之间的关系。定量感觉测试(QST)在 IVF 治疗过程中进行了两次:一次在激素下调期,一次在激素上调期。还检查了一组健康男性和一组使用单相避孕药的女性,以控制组内差异。在接受 IVF 的女性中,血清 17β-雌二醇水平如预期的那样在治疗中差异很大,从下调期的 65.7(SD=26)pmol/L 增加到上调期的 5188(SD=2524)pmol/L。QST 仅出现显著结果的是温度知觉阈值(1.7°C 对 2.2°C;P=0.003)和冷痛阈值(11.5°C 对 14.5°C;P=0.04)。然而,在 2 个对照组中也观察到了冷痛阈值的类似变化,但是统计分析表明,这种变化是由于组内差异,而不是激素调节的结果。热痛阈值、热耐量、压痛阈值和冷加压试验在不同的时间点之间没有显著差异。这些数据表明,即使血清雌二醇水平发生重大变化,健康女性的疼痛感知和疼痛阈值也几乎没有变化。
本研究表明,尽管治疗方案引起的 17β-雌二醇水平发生了显著变化,但接受体外受精的女性的疼痛感知和耐受性没有变化。因此,结果表明在人类中,与实验动物相反,雌激素水平的变化对疼痛敏感性影响很小。